News Articles Tagged: PDK Inhibitor

DCA and Cancer Therapy: Targeting Metabolism for a New Approach

Delve into how Sodium Dichloroacetate (DCA) targets cancer cell metabolism, exploring its potential as a synergistic agent in cancer treatment.

Understanding Dichloroacetate (DCA): A Metabolic Modulator for Cancer and Beyond

Explore the science behind Sodium Dichloroacetate (DCA), its mechanism in targeting cancer metabolism, and its potential applications in neuroprotection and metabolic health.